NCT03990805View on ClinicalTrials.gov

A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

June 11, 2019

Primary Completion Date

December 15, 2020

Study Completion Date

December 15, 2020

Conditions
Degenerative ArthritisKnee Osteoarthritis
Interventions
BIOLOGICAL

JOINTSTEM

JOINTSTEM Autologous Adipose Tissue derived MSCs 1x10\^8cells/(saline), 1 time injection

DRUG

saline

saline, 1 time injection

Trial Locations (13)

28644

Chungbuk National University Hospital, Cheongju-si

42415

Yeungnam University Hospital, Daegu

42601

Keimyung University Dongsan Medical Center, Daegu

52727

Gyeongsang National University Hospital, Jinju

54907

Chonbuk National University Hospital, Jeonju

02447

Kyunghee University Medical Center, Seoul

03080

Seoul National University Hospital, Seoul

03722

Yonsei University Health System, Seoul

05278

KyungHee University Gangdong Hospital, Seoul

06273

Gangnam Severance Hospital, Seoul

06351

Samsung Medical Center, Seoul

06591

Seoul St. Mary's Hospital, Seoul

06973

Chunang University Hospital, Seoul

Sponsors

Lead Sponsor

R-Bio
All Listed Sponsors
lead

R-Bio

INDUSTRY

NCT03990805 - A Phase 3 Study to Evaluate the Efficacy and Safety of JointStem in Treatment of Osteoarthritis | Biotech Hunter | Biotech Hunter